Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,324
Closed -$224K 300
2024
Q1
$224K Buy
+1,324
New +$248K 0.06% 271
2022
Q2
Sell
-2,049
Closed -$386K 239
2022
Q1
$386K Buy
2,049
+727
+55% +$144K 0.16% 114
2021
Q4
$323K Buy
+1,322
New +$290K 0.16% 142

Other funds holding ZTS

ASB Consultores's ZTS Position: Q2 2024 in Review

ASB Consultores sold out of Zoetis (ZTS) in Q2 2024, closing a stake of 1,324 shares — an estimated $224K sold.

ASB Consultores first reported a position in ZTS in Q4 2021 and held it in 3 quarters. The position peaked at $386K in Q1 2022. 1,733 funds tracked by Wall St. Rank hold ZTS as of Q2 2024.

  • ASB Consultores reported no remaining Zoetis position as of Q2 2024 after selling out during the quarter.
  • ASB Consultores sold 1,324 Zoetis shares in Q2 2024, an estimated $224K.
  • ASB Consultores first reported a position in Zoetis in Q4 2021 and held it in 3 quarters.
  • ASB Consultores's Zoetis position peaked at $386K in Q1 2022.
  • 1,733 funds tracked by Wall St. Rank held Zoetis as of Q2 2024.

Based on ASB Consultores's 13F filing for Q2 2024, filed 12 Aug 2024.